Financial Performance - Operating revenue for the first quarter was CNY 342,993,999, representing a decrease of 19.56% year-on-year[7]. - Net profit attributable to shareholders was CNY 8,677,484, down 63.44% compared to the same period last year[7]. - Basic earnings per share decreased by 50.00% to CNY 0.02 compared to CNY 0.04 in the previous year[7]. - The weighted average return on equity dropped to 0.33%, down 0.60 percentage points from the previous year[7]. - The net profit for Q1 2020 was CNY 11,008,981.12, a decrease of 47.97% compared to CNY 21,158,809.18 in the same period last year[12]. - Total revenue for Q1 2020 was ¥342,993,999.78, a decrease of 19.5% compared to ¥426,384,693.33 in Q1 2019[25]. - Net profit for Q1 2020 was ¥11,008,981.12, a decline of 48.0% from ¥21,158,809.18 in Q1 2019[26]. - The company reported a total comprehensive income of ¥3,607,340.58 for Q1 2020, significantly lower than ¥33,243,253.35 in Q1 2019[26]. - The total comprehensive income for Q1 2020 was a loss of CNY 8,880,376.17, compared to a gain of CNY 10,406,512.58 in Q1 2019[29]. Cash Flow - Cash flow from operating activities showed a net inflow of CNY 14,904,611, a significant decline of 71.69% year-on-year[7]. - The company's cash flow from operating activities decreased by 71.69% to CNY 14,904,611.03, down from CNY 52,642,944.73 in the previous year[12]. - The net cash flow from operating activities in Q1 2020 was CNY 14,904,611.03, down 71.7% from CNY 52,642,944.73 in Q1 2019[32]. - The company reported a significant decrease in cash inflows from operating activities, totaling CNY 368,423,652.45 in Q1 2020, compared to CNY 461,475,742.51 in Q1 2019, a decline of approximately 20.1%[32]. - The net cash flow from operating activities for Q1 2020 was -687,868.75, a decrease of 51% compared to -1,405,475.44 in Q1 2019[36]. - The cash and cash equivalents at the end of Q1 2020 were CNY 552,355,855.66, a decrease from CNY 596,052,428.52 at the beginning of the quarter[33]. Assets and Liabilities - Total assets at the end of the reporting period reached CNY 3,604,498,926, an increase of 1.36% compared to the end of the previous year[7]. - The total assets as of March 31, 2020, were CNY 3,604,498,925.99, compared to CNY 3,556,129,011.94 at the end of 2019[18]. - The total liabilities as of March 31, 2020, were CNY 939,360,580.74, an increase from CNY 894,598,007.27 year-on-year[19]. - Total liabilities for Q1 2020 were 894,598,007.27, remaining consistent with the previous year[41]. - Total assets amounted to approximately $2.03 billion, with current assets at about $219.79 million and non-current assets at approximately $1.81 billion[44]. - Total liabilities were reported at approximately $49.07 million, with current liabilities totaling around $33.51 million and non-current liabilities at about $15.55 million[45]. - The company’s total liabilities and shareholders' equity matched the total assets, confirming a balanced financial position at $2.03 billion[45]. Shareholder Information - The total number of shareholders at the end of the reporting period was 49,531[9]. - The largest shareholder, Guizhou Magic Investment Co., Ltd., held 131,301,620 shares, accounting for 24.59% of the total shares[9]. - The total equity attributable to shareholders as of Q1 2020 was 2,616,230,980.01, consistent with the previous year[41]. Research and Development - Research and development expenses increased by 43.35% to CNY 1,943,360.73 from CNY 1,355,690.42 year-on-year[12]. - Research and development expenses for Q1 2020 were ¥1,943,360.73, an increase from ¥1,355,690.42 in Q1 2019[25]. - The company incurred research and development expenses, although specific figures were not disclosed in the provided data[28]. Government Support and Non-Operating Loss - The company received government subsidies totaling CNY 976,277, which included various forms of support related to the COVID-19 pandemic[9]. - The company reported a significant non-operating loss of CNY 2,587,422 due to donations made in response to the pandemic[9]. - The company anticipates potential losses or significant changes in net profit compared to the previous year due to ongoing challenges[13].
神奇制药(600613) - 2020 Q1 - 季度财报